Artículo de revista
Monthly injectable steroid contraceptives and cervical carcinoma
Fecha
1989Registro en:
American Journal of Epidemiology, Volumen 130, Issue 2, 2018, Pages 237-247
00029262
10.1093/oxfordjournals.aje.a115330
Autor
Thomas, David B.
Molina, Ramiro
Cuevas, Hector Rodriguez
Ray, Roberta M.
Riotton, Gustave
Dabancens, Alfredo
Benavides, Socorro
Martinez, Luis
Salas, Oriana
Pallet, Jose A.
Lopez, Jorge
Institución
Resumen
The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives is a large multinational hospital-based case-control study of steroid contraceptives and gynecologic, hepatobiliary, and mammary neoplasms. Monthly injectable steroid contraceptives which contained the long-acting pro-gestogen dihydroxyprogesterone acetofenide plus a shorter-acting estrogen (usually estradiol enanthate) were used by women in two of the countries (Chile and Mexico) from which data were collected. In preliminary analyses of data from Chile (1979-1983), a strong association was observed between use of these products and invasive cervical cancer. Therefore, three additional data sets from these two countries were analyzed in further detail for this report. Analyses of additional data from Chile on invasive cervical cancer (1983-1985) and cervical carcinoma in situ (1979-1986) and of data on invasive cervical cancer from Mexico (1979-1986) failed to confirm the initially observed assoc